Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The LOW Study
NCT00238004Phase 4Unknown
- Sponsor
- Craigavon Area Hospital
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in coronary heart disease (CHD) and low hdl cholesterol comparing Niaspan + Statin with Placebo + Statin (2 arms). Primary endpoint: Number of patients achieving target HDL-C levels at 15 weeks. Status: unknown.
02
Drugs
niacin
03
Conditions
coronary heart disease (CHD)low hdl cholesterol
Beyond the preview
Go deeper on NCT00238004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00238004.